CPB vs CTNM · P/E 12, rev $10.25B vs $429.6M cap
Campbell’s Co (CPB) versus Contineum Therapeutics, Inc. Class A Common Stock (CTNM) — a side-by-side from cached financials, not a winner call.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
CPB currently screens at market cap $6.46B and trailing P/E 11.8. CTNM currently screens at market cap $429.6M.
Not investment advice. Open the CPB and CTNM stock pages for the full models.
Not investment advice.